15 Growth Biotech Investors — 15 Currently Deploying

Kleiner Perkins partners with visionary founders to build transformative companies that change how the world works. The fund emphasizes team building, network facilitation, and bus…

Turn sci-fi into sci-fact by championing companies at the intersection of the new and not-yet-imagined, looking decades into the future to create a world most can barely imagine.

Bold, early, impactful ventures with brutal honesty. Believe in world-class teams making contrarian bets on impossibly big ideas, from AI to cleantech to deep tech.

Partner with visionary founders at the intersection of bold vision and relentless execution. Active investors seeking to be partners during the rapid growth stage of scaling journe…

Back the world's most ambitious entrepreneurs capable of building transformative businesses over 20+ years that solve fundamental problems across all sectors and geographies using …

Lundbeckfonden creates powerful ripple effects by actively investing in business and science at the frontiers of their fields, with focus on bringing discoveries to lives through b…

Deep tech venture capital backing brilliant entrepreneurs addressing the hardest, highest-stakes problems in the world, using AI to unlock potential across sectors.

Support domestic and international startups through capital provision and business collaboration, leveraging Dentsu Group's creative and strategic resources alongside global VC net…

Speedinvest provides European startups with 'more expertise, connections, reach, and momentum' through specialist investment teams across six core sectors, backing companies from s…

Partner with exceptional people to help them realize their full potential across pre-seed, seed, growth, and public market stages through long-term founder relationships.

Multi-stage venture capital firm that goes beyond traditional VC playbook by providing entrepreneurs support of a global ecosystem, connecting innovators everywhere.

A talent and research-driven investment firm that identifies and invests in a small number of entrepreneurs and companies they build, from seed to scale.

Partner with leading corporations to help launch and manage their venture capital programs, supporting portfolio companies across diverse sectors.

Partner with entrepreneurs from early days through every stage of growth, focusing on transformative technology across AI/ML, biotech, cloud, consumer, and crypto sectors.

How many growth biotech investors are actively deploying right now?

DryPowder tracks 15 growth biotech funds. Of these, 15 are currently deploying capital based on recent fund closes, portfolio activity, and partner signals. Use DryPowder's fund matching to see which ones fit your specific startup.

What check size do growth biotech VCs write?

Among 15 growth biotech funds on DryPowder, check sizes run from $100K–$50M. Ranges vary by fund size, vintage, and whether the fund leads rounds. Each fund profile shows check size detail and lead preference.

How do I get a meeting with a growth biotech VC?

A warm intro is still the fastest path. Most growth biotech VCs on DryPowder do accept cold outreach or direct applications, but response rates vary widely by fund. Before reaching out, use DryPowder's AI matching to get a fit score and specific talking points. Founders who lead with thesis-aligned framing get significantly better response rates than those sending the same deck to every fund on a list.

How is growth-stage fundraising different from earlier venture rounds?

Growth-stage processes resemble private equity diligence more than typical venture fundraising. Expect 4-8 months, financial audits, customer reference programs, and engagement at the CFO and board level. Most growth funds require 6-12 months of auditable financials and focus on financial performance, competitive moats, and management team depth rather than founder narrative.

How many growth biotech investors should I be talking to at once?

Most fundraisers recommend a parallel process: identify 20-40 target investors but approach your highest-fit funds first. Of the 15 growth biotech funds currently deploying, not all will match your specific stage and sector. Use fund matching to find your top 10-15, approach those first, collect feedback, then go wider. Going to every fund simultaneously without qualifying first burns bridges and dilutes the urgency that helps close a round.

How is DryPowder different from building a VC list on LinkedIn or Crunchbase?

The fund list you build on LinkedIn or Crunchbase is roughly the same list every other founder is building. DryPowder adds three things a manual search cannot: deployment signals (which funds have recently closed new vehicles and are actively writing checks), AI thesis matching (which of the 15 growth biotech funds actually fits your specific startup, ranked by fit), and verified partner contact details. The goal is 15 targeted, thesis-aligned pitches instead of 150 generic ones.